Lars Bossen

9PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersHaematological tumoursGastroenterology and hepatologyAutoimmunityRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 27, 2026
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort.

|Mar 18, 2026
Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis.

Lars Bossen, Henning Grønbæk, Peter Ott

|Mar 27, 2023
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis.

Lars Bossen, Tobias Stemann Lau, Mette Bak Nielsen

|Oct 28, 2022
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.

Tea Lund Laursen, Lars Bossen, Rasmus Pihl

|Jun 02, 2020
Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.

Henning Grønbaek, Holger Jon Møller, Faouzi Saliba

|Apr 13, 2020
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.

Lars Bossen, Paola Rebora, Francesca Bernuzzi

Pageof 2

Frequent Collaborators

3 joint publications

Henning Grønbaek

3 joint publications

Peter Jepsen

2 joint publications

Holger Jon Møller

2 joint publications

Pere Ginès